ID | Age | Sex | Stage | Outcome | Followup | Survival median | Site | WCA | WCA | SCA | SCA | MNA | 11q- | Array platform |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
(mo) | (INRGSS) | (mo) | (mo) | (nr) | (average) | (nr) | (average) | |||||||
52* | 4 | m | M | DOD | 10 | adr | 0 | 6 | + | 32K | ||||
55 | 8 | f | M | DOD | 16 | adr | 0 | 6 | + | 32K, Affymetrix | ||||
106* | 10 | f | M | NED | 265 | adr | 0 | 12 | + | 32K | ||||
123* | 11 | f | M | DOD | 3 | adr | 0 | 6 | + | 32K, Affymetrix | ||||
241* | 11 | m | M | DOD | 8 | adr | 1 | 3 | + | 32K, Affymetrix | ||||
244 | 14 | f | M | DOD | 22 | adr | 8 | 2 | + | Affymetrix | ||||
212 | 15 | m | M | DOD | 5 | adr | 0 | 2 | + | 32K, Affymetrix | ||||
240* | 21 | f | M | NED | 43 | adr | 0 | 3 | + | 32K, Affymetrix | ||||
135* | 22 | m | L2 | DOD | 3 | adr | 0 | 3 | + | 32K, Affymetrix | ||||
95* | 26 | f | M | DOD | 15 | adr | 0 | 8 | + | 32K | ||||
238 | 30 | f | M | DOD | 24 | adr | 0 | 6 | + | Affymetrix | ||||
207 | 37 | f | M | DOD | 7 | adr | 2 | 5 | + | 32K, Affymetrix | ||||
217 | 37 | m | M | DOD | 36 | adr | 0 | 8 | + | 32K | ||||
126 | 138 | m | M | DOD | 9 | adr | 0 | 7 | + | 32K, Affymetrix | ||||
MNA not11q- | 9.5 | 0.8 | 5.5 | |||||||||||
68 | 41 | m | M | DOD | 12 | adr | 9 | 7 | + | + | 32K, Affymetrix | |||
136* | 48 | f | L2 | DOD | 12 | adr | 1 | 8 | + | + | 32K | |||
MNA & 11q- | 12.0 | 5.0 | 7.5 | |||||||||||
243 | 32 | f | M | DOD | 28 | adr | 2 | 10 | + | Affymetrix | ||||
149 | 34 | m | M | DOD | 16 | adr | 0 | 12 | + | 32K, Affymetrix | ||||
112 | 40 | m | M | DOD | 18 | adr | 1 | 3 | + | 32K, Affymetrix | ||||
111* | 42 | f | M | NED | 262 | adr | 0 | 7 | + | 32K | ||||
155 | 52 | f | M | DOD | 19 | adr | 3 | 13 | + | 32K, Affymetrix | ||||
32* | 57 | m | M | DOD | 12 | adr | 2 | 15 | + | 32K, Affymetrix | ||||
110 | 60 | m | M | DOD | 12 | adr | 1 | 14 | + | 32K, Affymetrix | ||||
69* | 60 | m | L2 | DOD | 17 | th | 1 | 14 | + | 32K, Affymetrix | ||||
41* | 77 | f | M | DOD | 8 | th | 2 | 15 | + | 32K, Affymetrix | ||||
49 | 82 | m | M | DOD | 14 | adr | 3 | 10 | + | 32K, Affymetrix | ||||
209 | 129 | m | M | DOD | 35 | adr | 2 | 10 | + | 32K, Affymetrix | ||||
229 | 169 | m | L2 | DOD | 34 | adr | 1 | 21 | + | 32K, Affymetrix | ||||
11q- notMNA | 16.5 | 1.5 | 12.0 | |||||||||||
107* | 23 | m | M | DOD | 10 | adr | 1 | 2 | 32K, Affymetriix | |||||
131 | 37 | f | L2 | DOD | 21 | adr | 13 | 1 | 32K, Affymetriix | |||||
130 | 46 | m | M | DOD | 57 | adr | 0 | 3 | 32K, Affymetriix | |||||
208 | 59 | m | L2 | DOD | 25 | renal | 4 | 3 | 32K | |||||
242* | 90 | f | M | SD | 37 | th | 12 | 5 | 32K, Affymetriix | |||||
226* | 91 | m | M | SD | 61 | th | 2 | 12 | 32K, Affymetriix | |||||
Not MNA not 11q- | 23.0 | 5.3 | 4.3 |